Sahil Khanna Selected Research

Fecal Microbiota Transplantation

1/2022	Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis.
1/2022	Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection.
12/2021	Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
10/2021	Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
10/2021	Gut microbiota: a target for intervention in obesity.
7/2021	Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
1/2021	Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
1/2021	Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2.
1/2021	My Treatment Approach to Clostridioides difficile Infection.
1/2021	Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sahil Khanna Research Topics

Disease

42	Clostridium Infections 06/2022 - 07/2012
14	Infections 01/2021 - 01/2012
12	Diarrhea 03/2022 - 08/2015
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 07/2013
5	Neoplasms (Cancer) 10/2021 - 07/2013
5	COVID-19 01/2021 - 01/2020
5	Dysbiosis 01/2020 - 01/2016
4	Microscopic Colitis 01/2022 - 02/2013
4	Colitis 10/2021 - 07/2015
4	Obesity 10/2021 - 01/2014
3	Melanoma (Melanoma, Malignant) 10/2021 - 07/2015
3	Crohn Disease (Crohn's Disease) 01/2018 - 02/2013
3	Ulcerative Colitis 01/2018 - 01/2016
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2014
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2022 - 02/2020
2	Reinfection 01/2021 - 07/2012
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021 - 01/2017
2	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 01/2019 - 01/2017
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Overweight 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Lung Neoplasms (Lung Cancer) 10/2019
1	Polyps 01/2018
1	Diabetes Mellitus 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Urinary Tract Infections (Urinary Tract Infection) 10/2017
1	Pouchitis 01/2017
1	Anastomotic Leak 01/2017
1	Fistula 01/2017
1	Hemorrhage 01/2017
1	Surgical Wound Infection 01/2017
1	Coinfection 11/2016
1	Body Weight (Weight, Body) 08/2015
1	Colorectal Neoplasms (Colorectal Cancer) 07/2013
1	Sclerosing Cholangitis 07/2013

Drug/Important Bio-Agent (IBA)

23	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2012
5	Vancomycin FDA LinkGeneric 04/2022 - 06/2014
5	Pharmaceutical PreparationsIBA 04/2022 - 07/2015
4	Proton Pump InhibitorsIBA 01/2021 - 07/2012
4	Monoclonal AntibodiesIBA 01/2021 - 11/2012
3	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 02/2013
3	IpilimumabIBA 10/2021 - 07/2015
3	VaccinesIBA 01/2021 - 08/2019
3	FidaxomicinIBA 01/2021 - 11/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 02/2013
2	Metronidazole (Metric)FDA LinkGeneric 01/2021 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2018
2	Immunologic Factors (Immunomodulators)IBA 01/2019 - 01/2018
2	TetracyclinesIBA 01/2018 - 01/2018
2	SteroidsIBA 01/2017 - 08/2015
2	Prednisone (Sone)FDA LinkGeneric 08/2015 - 02/2013
1	HDL CholesterolIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Apolipoproteins B (ApoB)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	LipidsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 10/2021
1	remdesivirIBA 01/2021
1	bezlotoxumabIBA 01/2021
1	actoxumabIBA 01/2021
1	IgYIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Anti-Infective Agents (Microbicides)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Amino Acids FDA Link 10/2018
1	Proline (L-Proline)FDA Link 10/2018
1	Biological ProductsIBA 01/2018
1	Shiga Toxin (Shigella Toxin)IBA 01/2018
1	Histamine H2 AntagonistsIBA 01/2017
1	Infliximab (Remicade)FDA Link 08/2015
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 07/2013
1	DeuteriumIBA 02/2013
1	AntigensIBA 02/2013
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2012
1	AcidsIBA 07/2012

Therapy/Procedure

25	Fecal Microbiota Transplantation 01/2022 - 11/2012
22	Therapeutics 01/2022 - 11/2012
3	Colectomy 01/2021 - 11/2016
2	Transplantation 06/2022 - 07/2015
1	Retreatment 03/2022
1	Aftercare (After-Treatment) 03/2022
1	Personal Protective Equipment 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Donor Selection 01/2021
1	Organ Transplantation 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2018
1	Length of Stay 01/2018
1	Drug Therapy (Chemotherapy) 11/2017
1	Restorative Proctocolectomy 01/2017
1	Ileostomy 01/2017
1	Appendectomy 04/2013
1	Immunotherapy 02/2013